{"id": "EUVD-2025-200322", "enisaUuid": "3484a1bc-3cbd-3c48-a9e1-f8643f7f9de2", "description": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.", "datePublished": "2025-12-02T21:07:47", "dateUpdated": "2025-12-09T17:03:27", "baseScore": 8.7, "baseScoreVersion": "4.0", "baseScoreVector": "CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:L/SC:N/SI:N/SA:N", "references": ["https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01", "https://nvd.nist.gov/vuln/detail/CVE-2025-61940"], "aliases": ["CVE-2025-61940"], "assigner": "icscert", "epss": 0.07, "enisaIdProduct": [{"id": "acf5596e-532b-3b3d-96d4-576de71a6e9b", "product": {"name": "EC2 Software NMIS BioDose"}, "product_version": ""}, {"id": "bca3d24e-7779-32b0-bbbf-305989aacef9", "product": {"name": "EC2 Software NMIS BioDose"}, "product_version": "0 <23.0"}], "enisaIdVendor": [{"id": "92da1178-d72f-34f7-bb73-866f3514250e", "vendor": {"name": "Mirion Medical"}}], "isExploited": false}